Qure AI vs Riverain Technologies (2026)
Two thoracic imaging companies with different theories about why findings get missed. Qure detects across a broad chest radiograph findings set with the widest regulatory footprint in that modality, deployed into screening programmes where radiologist capacity is thinnest, and independently evaluated in a tuberculosis context. Riverain suppresses the vessels, on the argument that nodules are missed because vasculature hides them rather than because nobody looked, which changes what the radiologist sees rather than adding a list. Those are complementary interventions and a lung programme could justify both. Neither publishes a security attestation, and both should be asked how they perform on your scanners, because thoracic algorithms are unusually sensitive to acquisition and degrade quietly when they move.
- It detects and localises across a large chest radiograph findings set with longitudinal comparison against prior scans, plus lung nodule work on computed tomography.
- Independent evaluation in a tuberculosis screening context tests the product where reading capacity is thinnest, which is a harder setting than a reading room study.
- On premise or cloud integration means images can stay inside the institution.
- Vessel suppression is a specific technical answer to a specific failure, making nodules visible that vasculature obscures rather than listing more findings.
- Long established thoracic focus means the products have been in clinical use across several generations of scanner and protocol change.
- For a lung nodule programme, a tool designed around why nodules are missed is different from a general findings detector.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Qure AI and Riverain Technologies are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Qure AI | Riverain Technologies |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2016 | 2000 |
| Headquarters | Mumbai, India | Dayton, Ohio, United States |
| Website | qure.ai | riveraintech.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Qure AI its top capability grade on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Set against Riverain Technologies, Qure AI grades higher on several axes, including Model and Technology Transparency, Clinical and Operational Evidence and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Riverain Technologies its top capability grade on AI Centrality. Set against Qure AI, Riverain Technologies grades higher on EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Qure AI or Riverain Technologies?
On the axes where the AI Health Index separates them, Qure AI grades higher on several axes, including Model and Technology Transparency, Clinical and Operational Evidence and Security Certifications and Trust Center, and Riverain Technologies grades higher on EHR and Interoperability Depth. Qure AI leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Qure AI and Riverain Technologies differ most?
The widest separation the AI Health Index records between Qure AI and Riverain Technologies is on Setting and Specialty Coverage, where Qure AI grades A and Riverain Technologies grades C. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.
Where do Qure AI and Riverain Technologies grade the same?
The AI Health Index grades Qure AI and Riverain Technologies the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Do not compare these on findings counts, because suppression changes what the reader sees while detection lists what the model found, and a department may reasonably use both. Neither publishes a security attestation or trust centre, which this index records as a pattern across non United States imaging vendors rather than a fault unique to either. Ask both for performance on your own scanner mix and protocols, since thoracic algorithms are sensitive to acquisition parameters and degrade quietly when they move.